Discussion of the two biologies of DLBCL - the GCB and ABC subtype and potential targeted therapies
Nivolumab in combination with azacytidine in patients with relapsed acute myeloid leukemia (AML)
Naval G. Daver
Results of CheckMate 039 trial of nivolumab in combination with ipilimumab for Hodgkin lymphoma
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
The FORTE clinical trial of carfilzomib in multiple myeloma